From: Sublingual sugar for hypoglycaemia in children with severe malaria: A pilot clinical study
Sublingual Sugar (SLS) | Intravenous Glucose (IVG) | p | |
---|---|---|---|
n = 14 (95%CI) | n = 9 (95%CI) | ||
Primary Outcome measure | |||
- Treatment Response (reaching 60 mg within 40 minutes) | 10/14 (71%) | 6/9 (67%) | 0.81 |
Secondary outcome measures | |||
- Early treatment responsea | 9/14 (64.3%) | 6/9 (67%) | 0.91 |
- Relapseb (as % of treatment responders) | 3/10 (30%) | 1/6 (17%) | 0.55 |
-CGmaxd(mg/dl) | 43.4 (25.8–62.5) | 46.2 (19.1–73.2) | 0.60 |
-Treatment delay (mins)e | < 5 | 18.9 (6.4–31.6) | - |
Case Fatality | 1 (7%) | 1 (11%) | NS |